Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Debat Pharmaceuticals
Garches, France
- Ownership
- Private
- Development stage
- Other
01
Overview
Laboratoires Débat was a prominent French pharmaceutical company that specialized in the development of treatments for urological and gastrointestinal conditions. The company is best known for its pioneering work with botanical extracts, specifically the development of Tadenan (Pygeum africanum) for the treatment of benign prostatic hyperplasia. Additionally, the company developed Debridat (trimebutine), a widely utilized musculotropic antispasmodic for functional bowel disorders. Following a period of significant growth in the mid-20th century, the company was acquired by Synthelabo in 1973 and was eventually integrated into the global healthcare leader Sanofi.
- Therapeutic areas
- GastroenterologyMen's Health
- Modalities
- Small moleculeBotanical extract
- Industry
- Biotech
02
Partnerships
Synthelabo
Beyond the preview
Go deeper on Debat Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Debat Pharmaceuticals.